{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:32:54Z","timestamp":1776094374038,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP0106"],"award-info":[{"award-number":["MLP0106"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cellimm.2022.104529","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T21:38:59Z","timestamp":1650922739000},"page":"104529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"375","author":[{"given":"Deep Chandra","family":"Balodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apeksha","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthik","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-3185","authenticated-orcid":false,"given":"Neena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10151","key":"10.1016\/j.cellimm.2022.104529_b0005","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2022.104529_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis : a review","volume":"6","author":"Torres-guerrero","year":"2017","journal-title":"F1000Research"},{"issue":"12","key":"10.1016\/j.cellimm.2022.104529_b0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/microorganisms7120695","article-title":"Protective or detrimental? understanding the role of host immunity in leishmaniasis","volume":"7","author":"dos Santos Meira","year":"2019","journal-title":"Microorganisms."},{"key":"10.1016\/j.cellimm.2022.104529_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12862-015-0538-3","article-title":"Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas","volume":"15","author":"Chauhan","year":"2015","journal-title":"BMC Evol. Biol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0025","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40291-018-0343-y","article-title":"Molecular diagnosis of visceral leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Mol. Diagn. Ther."},{"issue":"11","key":"10.1016\/j.cellimm.2022.104529_b0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Trop. Med. Int. Heal."},{"key":"10.1016\/j.cellimm.2022.104529_b0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: Newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop. Parasitol."},{"key":"10.1016\/j.cellimm.2022.104529_b0040","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3389\/fimmu.2017.01943","article-title":"Immunomodulatory therapy of visceral leishmaniasis in human immunodeficiency virus-coinfected patients","volume":"8","author":"Adriaensen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms8081201","article-title":"Leishmania immunity: Advancing immunotherapy and vaccine development","volume":"8","author":"Ikeogu","year":"2020","journal-title":"Microorganisms."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104529_b0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.vaccine.2011.11.005","article-title":"The development and clinical evaluation of second-generation leishmaniasis vaccines","volume":"30","author":"Duthie","year":"2012","journal-title":"Vaccine."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: A review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.cellimm.2022.104529_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2015.03.017","article-title":"Vaccines for visceral leishmaniasis: A review","volume":"422","author":"Jain","year":"2015","journal-title":"J. Immunol. Methods Epub."},{"key":"10.1016\/j.cellimm.2022.104529_b0065","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3389\/fimmu.2018.02420","article-title":"heterologous immunization with defined RNA and subunit vaccines enhances T cell responses that protect against Leishmania donovani","volume":"17","author":"Duthie","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0070","article-title":"A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104529_b0075","doi-asserted-by":"crossref","first-page":"e0009627","DOI":"10.1371\/journal.pntd.0009627","article-title":"Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis","volume":"15","author":"Helou","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2-3","key":"10.1016\/j.cellimm.2022.104529_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00430-021-00703-8","article-title":"Potential biomarkers of immune protection in human leishmaniasis","volume":"210","author":"Rostami","year":"2021","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0085","doi-asserted-by":"crossref","first-page":"111671","DOI":"10.1016\/j.biopha.2021.111671","article-title":"Host immune response against leishmaniasis and parasite persistence strategies: A review and assessment of recent research","volume":"139","author":"Elmahallawy","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cellimm.2022.104529_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of Cytokines in Experimental and Human Visceral Leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front. Cellular Infect. Microbiol."},{"issue":"1-2","key":"10.1016\/j.cellimm.2022.104529_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0264-410X(01)00322-X","article-title":"Immunization with A2 protein results in a mixed Th1\/Th2 and a humoral response which protects mice against Leishmania donovani infections","volume":"20","author":"Ghosh","year":"2001","journal-title":"Vaccine."},{"key":"10.1016\/j.cellimm.2022.104529_b0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: Key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0105","doi-asserted-by":"crossref","first-page":"155297","DOI":"10.1016\/j.cyto.2020.155297","article-title":"Cytokine Review article A historical review of the role of cytokines involved in leishmaniasis","volume":"145","author":"Mirzaei","year":"2021","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0110","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/jcp.30029","article-title":"Neutrophils and Visceral Leishmaniasis: Impact on innate immune response and cross-talks with macrophages and dendritic cells","volume":"236","author":"Kupani","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cellimm.2022.104529_b0115","doi-asserted-by":"crossref","first-page":"108400","DOI":"10.1016\/j.intimp.2021.108400","article-title":"Exploring the paradox of defense between host and Leishmania parasite","volume":"102","author":"Kumari","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.cellimm.2022.104529_b0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fimmu.2012.00069","article-title":"Vaccines for Canine Leishmaniasis","volume":"3","author":"Palatnik-De-Sousa","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"Sundar","year":"2014","journal-title":"Expert Rev. Vaccines."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104529_b0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijpara.2012.02.013","article-title":"A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis","volume":"42","author":"Gupta","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.cellimm.2022.104529_b0140","doi-asserted-by":"crossref","first-page":"B244","DOI":"10.1016\/j.vaccine.2012.11.080","article-title":"Case study for a vaccine against leishmaniasis","volume":"31","author":"Alvar","year":"2013","journal-title":"Vaccine."},{"issue":"9","key":"10.1016\/j.cellimm.2022.104529_b0145","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/iai.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis","volume":"63","author":"Soong","year":"1995","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104529_b0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molbiopara.2005.09.014","article-title":"Cloning and characterization of angiotensin converting enzyme related dipeptidylcarboxypeptidase from Leishmania donovani","volume":"145","author":"Goyal","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.cellimm.2022.104529_b0155","first-page":"56","article-title":"Biochemical characterization of dipeptidylcarboxypeptidase of Leishmania donovani","volume":"57","author":"Baig","year":"2011","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.cellimm.2022.104529_b0160","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1747-0285.2011.01262.x","article-title":"identification of novel inhibitors of dipeptidylcarboxypeptidase of Leishmania donovani via ligand-based virtual screening and biological evaluation","volume":"79","author":"Gangwar","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"issue":"8","key":"10.1016\/j.cellimm.2022.104529_b0165","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00669-20","article-title":"TCP1\u03b3 Subunit is indispensable for growth and infectivity of leishmania donovani","volume":"64","author":"Yadav","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104529_b0170","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-\u03b3 and IL-12 response in cured Leishmania-infected patients\/hamsters and protects hamsters against Leishmania challenge","volume":"187","author":"Kushawaha","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exppara.2014.08.016","article-title":"Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis","volume":"146","author":"Eskandari","year":"2014","journal-title":"Exp. Parasitol."},{"issue":"1-2","key":"10.1016\/j.cellimm.2022.104529_b0180","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0185","doi-asserted-by":"crossref","first-page":"e86073","DOI":"10.1371\/journal.pone.0086073","article-title":"Characterization of glycolytic enzymes - rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis","volume":"9","author":"Gupta","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cellimm.2022.104529_b0190","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ygeno.2009.01.007","article-title":"Genome-wide analysis reveals increased levels of transcripts related with infectivity in peanut lectin non-agglutinated promastigotes of Leishmania infantum","volume":"93","author":"Alcolea","year":"2009","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-Type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"Samant","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"6","key":"10.1016\/j.cellimm.2022.104529_b0205","doi-asserted-by":"crossref","first-page":"e97911","DOI":"10.1371\/journal.pone.0097911","article-title":"Nucleosomal histone proteins of L. donovani: A combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters","volume":"9","author":"Baharia","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.biochem.71.090501.145453","article-title":"Biological roles of proteases in parasitic protozoa","volume":"71","author":"Klemba","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cellimm.2022.104529_b0215","first-page":"363","article-title":"Protease inhibitors in potential drug development for leishmaniasis","volume":"50","author":"Das","year":"2013","journal-title":"Indian J. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104529_b0220","doi-asserted-by":"crossref","first-page":"e14644","DOI":"10.1371\/journal.pone.0014644","article-title":"Potency, efficacy and durability of DNA\/DNA, DNA\/ protein and protein\/protein based vaccination using gp63 against Leishmania donovani in BALB\/c mice","volume":"6","author":"Mazumder","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2022.104529_b0225","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1128\/iai.61.8.3351-3359.1993","article-title":"Recombinant vaccinia viruses expressing GP46\/M-2 protect against Leishmania infection","volume":"61","author":"McMahon-Pratt","year":"1993","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.cellimm.2022.104529_b0230","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0014-4894(92)90179-E","article-title":"Leishmania major: Differential regulation of the surface metalloprotease in amastigote and promastigote stages","volume":"75","author":"Schneider","year":"1992","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbrc.2008.05.162","article-title":"A proposed role for Leishmania major carboxypeptidase in peptide catabolism","volume":"373","author":"Isaza","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.cellimm.2022.104529_b0240","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/IAI.00864-06","article-title":"Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccin, e infection and immunity","volume":"75","author":"Lavazec","year":"2007","journal-title":"Infect. Immunity"},{"key":"10.1016\/j.cellimm.2022.104529_b0245","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.4049\/jimmunol.153.11.5158","article-title":"A protective \u201cconcealed\u201d antigen from Boophilus microplus. purification, localization, and possible function","volume":"11","author":"Riding","year":"1994","journal-title":"J Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2022.104529_b0250","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/pim.12189","article-title":"Immunostimulatory potential and proteome profiling of Leishmania donovani soluble exogenous antigens","volume":"37","author":"Kumar","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0255","doi-asserted-by":"crossref","first-page":"e0003557","DOI":"10.1371\/journal.pntd.0003557","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis., PLoS Negl","volume":"9","author":"Baharia","year":"2015","journal-title":"Trop. Dis."},{"key":"10.1016\/j.cellimm.2022.104529_b0260","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molimm.2021.11.009","article-title":"Immunological characterization of rLdTCP1\u03b3 for its prophylactic potential against visceral leishmaniasis in hamster model","volume":"141","author":"Anand","year":"2022","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2022.104529_b0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00436-013-3716-5","article-title":"Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis","volume":"113","author":"Khare","year":"2014","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cellimm.2022.104529_b0270","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"6","author":"Jaiswal","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.cellimm.2022.104529_b0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1674-8301(10)60004-8","article-title":"A review of adjuvants for vaccine candidates","volume":"24","author":"Mutiso","year":"2010","journal-title":"J. Biomed. Res."},{"issue":"15-16","key":"10.1016\/j.cellimm.2022.104529_b0280","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.vaccine.2003.11.014","article-title":"Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis","volume":"22","author":"Zadeh-Vakili","year":"2004","journal-title":"Vaccine."},{"issue":"46","key":"10.1016\/j.cellimm.2022.104529_b0285","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals","volume":"26","author":"Khoshgoo","year":"2008","journal-title":"Vaccine."},{"issue":"16","key":"10.1016\/j.cellimm.2022.104529_b0290","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1016\/j.vaccine.2006.01.030","article-title":"Comparison of potential protection induced by three vaccination strategies (DNA\/DNA, Protein\/Protein and DNA\/Protein) against Leishmania major infection using signal peptidase type I in BALB\/c mice","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine."},{"issue":"5","key":"10.1016\/j.cellimm.2022.104529_b0295","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.chom.2020.03.011","article-title":"Th1-Th2 cross-regulation controls early leishmania infection in the skin by modulating the size of the permissive monocytic host cell reservoir, cell host microbe","volume":"27","author":"Carneiro","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.cellimm.2022.104529_b0300","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2022.104529_b0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pt.2015.08.001","article-title":"Induction, propagation, and activity of host nitric oxide: lessons from Leishmania infection","volume":"31","author":"Olekhnovitch","year":"2015","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.cellimm.2022.104529_b0310","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4049\/jimmunol.136.2.655","article-title":"Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro","volume":"2","author":"Sadick","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0315","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"natural killer cell stimulatory factory (interleucin 12 [IL-12]) induces responses and inhibits the dedevelopment of IL-4-producing Th Cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2022.104529_b0320","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4049\/jimmunol.155.2.730","article-title":"Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice","volume":"155","author":"Heinzel","year":"1995","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2022.104529_b0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.iy.10.040192.002125","article-title":"Regulation of immunity to parasites by T cells and T cell-derived cytokines","volume":"10","author":"Sher","year":"1992","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2022.104529_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-\u03b3 plasma levels in human visceral leishmaniasis: Implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cellimm.2022.104529_b0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fimmu.2012.00251","article-title":"Immunobiology of visceral leishmaniasis","volume":"3","author":"Kumar","year":"2012","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922000533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874922000533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:09:49Z","timestamp":1757804989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874922000533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":67,"alternative-id":["S0008874922000533"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104529","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2022.104529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104529"}}